Expression of retinoid receptor genes and proteins in non-small-cell lung cancer

Journal of the National Cancer Institute

Volumn 91, Issue 12, 1999, Pages 1059-1066

  Picard, Evelyne ^b   Seguin, Carole ^b   Monhoven, Nathalie ^b   Rochelte Egly, Cécile ^b   Siat, Joelle ^b   Borrelly, Jacques ^b   Martinet, Yves ^b   Martinet, Nadine ^b   Vignaud, Jean Michel ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR ANTIBODY; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE;

EID: 0033575058     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.12.1059     Document Type: Article

References (56)

1. Silverberg E, Boring CC, Squires TS. Cancer statistics. CA Cancer J Clin 1990;40:9-26.
2. McDowell EM, Ben T, Coleman B, Chang S, Newkirk C, De Luca LM. Effects of retinoic acid on the growth and morphology of hamster tracheal epithelial cells in primary culture. Virchows Arch B Cell Pathol Incl Mol Pathol 1987;54:38-51.
3. Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994;12:937-45.
4. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996;10:1031-9.
5. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 1994; 86:140-1.
6. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278: 1073-7.
7. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10: 940-54.
8. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 1995; 83:859-69.
9. Leid N, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 1992;17: 427-33.
10. De The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 1990;343:177-80.
11. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-9.
12. Gudas LJ, Sporn MB, Roberts AB, Goodman DS. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodmans DS, editors. The retinoids. New York (NY): Raven Press; 1994. p. 443-520.
13. Oridate N, Lotan D. Xu XC, Hong WK, Lotan R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydoxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 1996;2:855-63.
14. Lu XP, Fanjul A, Picard N, Pfahl M, Rungta D, Nared-Hood K, et al. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat Med 1997;3:686-90.
15. Li Y, Dawson MI, Agadir A, Lee MO, Jong L, Hobbs PD, et al. Regulation of RARβ expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Int J Cancer 1998;75:88-95.
16. Crowe DL. Retinoic acid receptor β induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression. Cancer Res 1998;58:142-8.
17. Guerin E, Ludwig MG, Basset P, Anglard P. Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression. J Biol Chem 1997;272: 11088-95.
18. Han GR, Dohi DF, Lee HY, Rajah R, Walsh GL, Hong WK, et al. All-tran-retinoic acid increases transforming growth factor-β2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-α-dependent signaling pathway. J Biol Chem 1997;272:13711-6.
19. Liu M, Iavarone A, Freedman LP. Transcriptional activation of the human p21 (WAF1/ C1P1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 1996;271:31723-8.
20. Zhang XK, Liu Y, Lee MO, Pfahl M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 1994;54:5663-9.
21. Boehm MF, Zhang L, Zhi L, McClurg MR, Berger E, Wagoner M, et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 1995;38:3146-55.
22. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, et al. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small-cell lung carcinoma cells. Cancer Res 1997;57: 4931-9.
23. Sun SY, Yue P, Shroot B, Hong WK, Lotan R. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437. J Cell Physiol 1997;173:279-84.
24. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995;332:1405-10.
25. Xu XC, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, et al. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst 1997;89:624-9.
26. Toulouse A, Morin J, Ying Y, Ayoub J, Bradley WE. Retinoic acid receptor β: an exploration of its role in lung cancer suppression and its potential in cancer prevention. In: Martinet Y, Hirsch FR, Martinet N, Vignaud JM, Mushine JL, editors. Clinical and biological basis of lung cancer prevention. Basel (Switzerland): Birkhäuser Verlag; 1998. p. 193-205.
27. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 1991;6:1859-68.
28. Houle B, Leduc F, Bradley WC. Implication of RARβ in epidermoid (squamous) lung cancer. Gene Chromosome Cancer 1991;3:358-66.
29. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 1994;54:3580-7.
30. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, et al. Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997;57:4158-61.
31. Xu XC, Sneige N, Liu X, Nangagiri R, Lee JJ, Lukmanji F, et al. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 1997;57:4992-6.
32. Houle B, Rochette-Egly C, Bradley WE. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993;90: 985-9.
33. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22.
34. nd ed. New York (NY): Springer-Verlag; 1981.
35. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-233S.
36. Gaub MP, Rochette-Egly C, Lutz Y, Ali S, Matthes H, Scheuer I, et al. Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res 1992;201:335-46.
37. Rochette-Egly C, Lutz Y, Pfister V, Heyberger S, Scheuer I, Chambon P, et al. Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. Biochem Biophys Res Commun 1994;204:525-36.
38. Rochette-Egly C, Gaub MP, Lutz Y, Ali S, Scheuer I, Chambon P. Retinoic acid receptor-β: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol 1992;6: 2197-209.
39. Rochette-Egly C, Lutz Y, Saunders M, Scheuer I, Gaub MP, Chambon P. Retinoic acid receptor γ: specific immunodetection and phosphorylation. J Cell Biol 1991;115:535-45.
40. Sapin V, Dolle P, Hindelang C, Kastner P, Chambon P. Defects of the chorioallantoic placenta in mouse RXR alpha null fetuses. Dev Biol 1997;191:29-41.
41. Ghyselinck NB, Dupe V, Dierich A, Messaddeq N, Gamier JM, Rochette-Egly C, et al. Role of the retinoic acid receptor beta (RARβ) during mouse development. Int J Dev Biol 1997;41:425-47.
42. Bobrow MN, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J Immunol Methods 1991;137:103-12.
43. Vignaud JM, Marie B, Klein N, Plenat F, Pech M, Borrelly J, et al. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res 1994;54:5455-63.
44. Ferrari N, Pfeffer U, Tosetti F, Brigati C, Vidali G. An improved RT-PCR protocol for the quantitation of human retinoic acid receptor RNA. Exp Cell Res 1994;211:121-6.
45. Allen RC, Budowle B. The use of the polymerase chain reaction and the detection of amplified products. In: White BA, editor. Methods in molecular biology, PCR protocols, current methods and applications, vol 15. Clifton (NJ): Humana Press; 1993. p. 113-28.
46. Thiberville L, Bourguignon J, Metayer J, Bost F, Diarra-Mehrpour M, Bignon J, et al. Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer. Int J Cancer 1995;64:371-7.
47. Mendelsohn C, Mark M, Dolle P, Dierich A, Gaub MP, Krust A, et al. Retinoic acid receptor β2 (RAR β2) null mutant mice appear normal. Dev Biol 1994;166:246-58.
48. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995;55:135-40.
49. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
50. Minucci S, Leid M, Toyama R, Saint-Jeannet JP, Peterson VJ, Horn V, et al. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol Cell Biol 1997;17:644-55.
51. Wu Q, Li Y, Liu R, Agadir A, Lee MO, Liu Y, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 1997;16: 1656-69.
52. May M, Mengus G., Lavigne AC, Chambon P, Davidson I. Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J 1996;15: 3093-104.
53. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998;391:815-8.
54. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998;391:811-4.
55. Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses of putative acetyltransferase to the CREB-binding protein. Nat Genet 1996;14: 33-41.
56. Mulshine JL, De Luca LM, Dedrick RL. Regional delivery of retinoids: a new approach to early lung cancer intervention. In: Martinet Y, Hirsch FR, Martinet N, Vignaud JM, Mushine JL, editors. Clinical and biological basis of lung cancer prevention. Basel (Switzerland): Birkhäuser Verlag; 1998. p. 273-83.